Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

HMN 2024 – Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatments for this devastating childhood cancer. A study published in the British Journal of Cancer reveals three new subgroups of the most common type of neuroblastoma, each with different genetic traits, expected outcomes, and distinguishing features that offer […]
Read More